• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON CLAREON PANOPTIX TORIC TRIFOCAL UV ABSORBING IOL; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON CLAREON PANOPTIX TORIC TRIFOCAL UV ABSORBING IOL; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number CCWTT3
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product was not returned.Product history records were reviewed and the documentation indicated the product met release criteria.The product investigation could not identify a root cause for the reported complaint.The product has not been received to evaluate.Information was provided that a director of global quality customer and technical affairs reached out to the surgeon to discuss the case.There has been no response to requests for further discussion.File will be reopened when new information or the product is received.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A healthcare professional reported that, after intraocular lens implantation surgery, the patient experienced capsular phimosis and post operative 1 month, the best corrected visual acuity (bcva) was 20/20 for both the eyes and post operative 2 month, the best corrected visual acuity (bcva) was 20/30.
 
Additional Manufacturer Narrative
The provided photos were reviewed by gqca.Five slit lamp photos are present in the file (along with two additional duplicates).The images appear to be from separate dilated eyes showing various stages of aggressive fibrosis with membranous formation consistent with the reported events.The root cause for the reported complaint could not be determined.The provided photos were reviewed.A root cause could not be determined form the provided photos.Information was provided that a director of global quality customer and technical affairs reached out to the surgeon to discuss the case.There has been no response to requests for further discussion.File will be reopened when new information or the product is received.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON PANOPTIX TORIC TRIFOCAL UV ABSORBING IOL
Common Device Name
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key17931001
Report Number1119421-2023-01747
Device Sequence Number6401612
Product Code MJP
UDI-Device Identifier00380652457408
UDI-Public00380652457408
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/03/2026
Device Model NumberCCWTT3
Device Catalogue NumberCCWTT3.210
Device Lot Number15382510
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/18/2023
Supplement Date Received by Manufacturer10/16/2023
Initial Report FDA Received Date10/13/2023
Supplement Report FDA Received Date11/09/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured04/05/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-